Plenity: A Device For Weight Loss that Looks Like A Drug, And Is Sold Like A Consumer Product
Executive Summary
Medtech Insight spoke to the chief executive and chief operating officers of Plenity’s manufacturer, Gelesis, to learn more about its weight loss device.
You may also be interested in...
Gelesis Presents Data Showing GS200, The Device That Looks Like A Drug, Treats Obesity
Results of the LIGHT UP study, which included prediabetic and diabetic subjects, could support FDA approval of GS200.
Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust
2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public.
Deals Shaping The Industry, February 2024
An interactive look at pharma, medtech, and diagnostics deals made during February 2023. Data courtesy of Biomedtracker.